Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Clinical trial NCT00514904 · COMPLETED

Trial details

NCT number: NCT00514904
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal Meningococcal Vaccines

Start date: 2007-09-18
Primary completion: 2008-09-03
Enrollment: 1504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.